Aarti Pharmalabs releases Q2 FY26 investor presentation, highlighting CDMO leadership, regulatory credentials, and a diversified, expanding global footprint with international sales contributing over half of H1 FY26.
AI Assistant
Aarti Pharmalabs Ltd
2025
Announcement
Find Answers
Ask about any part of the document to get insights, explanations, or key details.